2020
DOI: 10.4103/ijo.ijo_2575_20
|View full text |Cite
|
Sign up to set email alerts
|

Central retinal vein occlusion with COVID-19 infection as the presumptive etiology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
55
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 91 publications
(56 citation statements)
references
References 11 publications
0
55
0
1
Order By: Relevance
“…The patient was put on a therapeutic dose of low-molecular-weight heparin (LMWH). Walinjkar et al [ 17 ] reported a 17-year-old COVID-19 patient with CRVO with macular edema, who was injected bevacizumab twice, and the visual acuity improved from 20/60 to 20/40 within 2 months.…”
Section: Resultsmentioning
confidence: 99%
“…The patient was put on a therapeutic dose of low-molecular-weight heparin (LMWH). Walinjkar et al [ 17 ] reported a 17-year-old COVID-19 patient with CRVO with macular edema, who was injected bevacizumab twice, and the visual acuity improved from 20/60 to 20/40 within 2 months.…”
Section: Resultsmentioning
confidence: 99%
“… 10 Moreover, retinal hemorrhages, central retinal vein occlusion and other retinal thrombotic complications have been observed in COVID-19 patients. 11 , 12 …”
Section: Discussionmentioning
confidence: 99%
“…10 Moreover, retinal hemorrhages, central retinal vein occlusion and other retinal thrombotic complications have been observed in COVID-19 patients. 11,12 Here, we described three cases of uveitis developing a few weeks after diagnosis of COVID-19, new mutations of the virus are still emerging which should raise red flags for possibly more severe complications and higher rates of infection. The COVID-19 pathophysiology is still not well understood as many factors affect the prognosis.…”
Section: Discussionmentioning
confidence: 99%
“…Apart from this, there were 6 (3.29%) review articles viz., teleophthalmology,[ 23 ] COVID-19 prophylaxis,[ 24 ] long-term corneal preservation techniques,[ 25 ] therapeutic opportunities to manage COVID-19,[ 26 ] lessons learned during COVID-19 pandemic,[ 4 ] and ophthalmic manifestations of COVID-19. [ 27 ] Surprisingly, there were only five (2.74%) case report, one (0.54%) on follicular conjunctivitis,[ 28 ] two (0.10%) on central retinal vein occlusion (CRVO),[ 29 30 ] one on (0.54%) COVID-19-associated papilledema,[ 31 ] and one on (0.54%) Adie–Holmes syndrome associated with COVID-19[ 32 ] probably owing to lack of documented evidence and COVID-19 testing facilities at majority centers in India. In addition, there were three (1.64%) articles on current ophthalmology, which added flavor and value to the COVID-19 research.…”
Section: Discussionmentioning
confidence: 99%